GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...

GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced the commercial availability of GONITRO™ (nitroglycerin) sublingual ...

Product: Nitroglycerin 0.4 MG/ACT sprays and Nitrostat 0.3mg/0.6mg sublingual tablets (added on May 10, 2023) What to do: Speak with your healthcare professional about how best to manage any impact of ...

OTTAWA Health Canada is advising consumers that Mylan Pharmaceuticals ULC has begun a voluntary recall of certain lots of a nitroglycerin heart medication from retailers. Some lots of the product, ...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent ...

Pune, Maharashtra, November 14 2022 (Wiredrelease) Market.Biz –:Global Medical Nitroglycerin Spray Market report provides a holistic assessment of the worldwide and regional market for the forecast ...

Emergency departments across the United States are facing a shortage of intravenous nitroglycerin, a drug commonly used to treat heart complications. Here are six alternatives to intravenous ...

What to do: Speak with your healthcare professional about how best to manage any impact of this shortage. Obtain only the amount you need. Keep expired product and check the table below to determine ...